Loading
Life sciences · Review
P a Herzen Journal of Oncology · October 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Improved surgical outcomes in patients with pancreatic cancer are largely associated with atraumatic and precise surgical technique. In this context, the most accurate determination of tumor localization, size, and metastases is particularly important. This can be achieved through fluorescence imaging (FI). It allows not only for specifying the localization of tumor foci and mapping lymphatic collectors, but also for a fairly accurate assessment of organ and tissue perfusion. Objective. Systematic review aims to determine the feasibility of using FI in pancreatic surgery (PROSPERO ID: CRD42023475963). Material and methods. The literature search was conducted using the MEDLINE, Embase, and e-Library databases from 31 of October, 2023 y., to 30 of June, 2024 y. This systematic review included all studies describing the use of FI during pancreatic surgery. Results. A total of 383 patients from 32 studies meeting the inclusion criteria were included in the review. The most commonly used fluorescent agent was indocyanine green (ICG), utilized in 28 studies. The authors cite the following important advantages of FI: more accurate determination of tumor and metastatic lesion localization, reliable assessment of organ blood supply and viability before and after resection, and a reduction in the risk of intraoperative injury to the common bile duct during pancreatic surgical interventions. Conclusion. FI in pancreatic surgery has a definite potential for detecting metastatic lesions not identified by radiological imaging methods, providing more precise visualization of tumors and resection margins, reducing the risk of intraoperative complications, and enabling reliable assessment of perfusion and viability of the pancreas, stomach, duodenum, spleen, and liver. This method may also be used to evaluate the effectiveness of neoadjuvant therapy in patients with pancreatic cancer.